Novo Nordisk AS (WBO:NNO2) Change In Inventory : €0 Mil (TTM As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Novo Nordisk AS Change In Inventory?

Novo Nordisk AS's change in inventory for the quarter that ended in Sep. 2024 was €0 Mil. It means Novo Nordisk AS's inventory stayed the same from Jun. 2024 to Sep. 2024 .

Novo Nordisk AS's change in inventory for the fiscal year that ended in Dec. 2023 was €-996 Mil. It means Novo Nordisk AS's inventory increased by €996 Mil from Dec. 2022 to Dec. 2023 .

Novo Nordisk AS's Total Inventories for the quarter that ended in Sep. 2024 was €5,089 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Novo Nordisk AS's Days Inventory for the quarter that ended in Sep. 2024 was 299.64.

Inventory Turnover measures how fast the company turns over its inventory within a year. Novo Nordisk AS's Inventory Turnover for the quarter that ended in Sep. 2024 was 0.30.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Novo Nordisk AS's Inventory-to-Revenue for the quarter that ended in Sep. 2024 was 0.52.

Novo Nordisk AS Change In Inventory Historical Data

The historical data trend for Novo Nordisk AS's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novo Nordisk AS Change In Inventory Chart

Novo Nordisk AS Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

-174.70

-120.30

-145.91

-640.77

-995.92

Novo Nordisk AS Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

Novo Nordisk AS Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

Novo Nordisk AS (WBO:NNO2) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Novo Nordisk AS's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	4980.057	/	1516.599	*	365 / 4
	=	299.64

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Novo Nordisk AS's Inventory Turnover for the quarter that ended in Sep. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	1516.599	/	4980.057
	=	0.30

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Novo Nordisk AS's Inventory to Revenue for the quarter that ended in Sep. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	4980.057	/	9564.039
	=	0.52

Novo Nordisk AS Change In Inventory Related Terms

Thank you for viewing the detailed overview of Novo Nordisk AS's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Novo Nordisk AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novo Nordisk AS (WBO:NNO2) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

NONOF:USA NVO:USA NOVOB:Mexico NVO:Mexico 0TDD:UK NOVOBc:UK 0QIU:UK NOVO B:Denmark NOV:Germany NOV:Germany NOVA:Germany NOV:Germany NOV:Germany NOVA:Germany N1VO34:Brazil NOV:Bulgaria

Address

Novo Alle 1, Bagsvaerd, DNK, 2880

Website

https://www.novonordisk.com

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Novo Nordisk AS Headlines

No Headlines